Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/02/2874641/0/en/Monte-Rosa-Therapeutics-Announces-the-Departure-of-Owen-Wallace-Ph-D-Chief-Scientific-Officer.html
https://www.globenewswire.com//news-release/2024/03/14/2846136/0/en/Monte-Rosa-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/03/11/2843611/0/en/Monte-Rosa-Therapeutics-Announces-Initiation-of-IND-Enabling-Studies-for-MRT-8102-A-First-in-Class-NEK7-Directed-Molecular-Glue-Degrader-and-NLRP3-IL-1%CE%B2-Pathway-Inhibitor.html
https://www.globenewswire.com/news-release/2024/01/31/2820942/0/en/Monte-Rosa-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/01/08/2805310/0/en/Monte-Rosa-Therapeutics-Provides-Corporate-Update-and-Key-Anticipated-Milestones-for-2024.html
https://www.globenewswire.com//news-release/2024/01/03/2803173/0/en/Monte-Rosa-Therapeutics-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/11/21/2783927/0/en/Monte-Rosa-Therapeutics-to-Present-at-Piper-Sandler-Healthcare-Conference.html
https://www.fiercebiotech.com/biotech/adaptimmune-monte-rosa-and-intellia-discontinue-programs
https://www.globenewswire.com//news-release/2023/11/09/2777173/0/en/Monte-Rosa-Therapeutics-Announces-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2023/11/07/2775281/0/en/Monte-Rosa-Therapeutics-Presents-Preclinical-Data-at-ACR-Convergence-2023-Demonstrating-Potential-of-MRT-6160-a-VAV1-targeted-Molecular-Glue-Degrader-to-Treat-Immunological-and-Inf.html